Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-27 @ 6:23 AM
Study NCT ID:
NCT01724866
Status:
COMPLETED
Last Update Posted:
2022-04-15
First Post:
2012-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2014-08-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-24
First Submit QC Date:
None
Study First Post Date:
2012-11-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-02-07
Results First Submit QC Date:
None
Results First Post Date:
2022-04-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-02-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-22
Last Update Post Date:
2022-04-15
Last Update Post Date Type:
ACTUAL